These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9866157)

  • 21. [Lack of association between 141C Ins/Del promoter polymorphism of DRD2 gene and schizophrenia].
    Kapelski P; Czerski PM; Godlewski S; Dmitrzak-Weglarz M; Hauser J
    Psychiatr Pol; 2002; 36(3):413-9. PubMed ID: 12149917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol.
    Mihara K; Suzuki A; Kondo T; Yasui-Furukori N; Ono S; Otani K; Kaneko S; Inoue Y
    Am J Med Genet; 2001 Apr; 105(3):271-4. PubMed ID: 11353448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association study between schizophrenia and dopamine D3 receptor gene polymorphism.
    Tanaka T; Igarashi S; Onodera O; Tanaka H; Takahashi M; Maeda M; Kameda K; Tsuji S; Ihda S
    Am J Med Genet; 1996 Jul; 67(4):366-8. PubMed ID: 8837704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [D3 dopamine receptor gene Ser9Gly polymorphism in Russian patients with schizophrenia].
    Aksenova MG; Shestakova IuN; Abramova LI; Frolova LP; Shemiakina TK; Lezheĭko TV; Lavrushina OM; Barkhatova AN; Nosikov VV; Golimbet VE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(10):57-61. PubMed ID: 15553379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Taq1A polymorphism in the dopamine D2 receptor gene predicts brain metabolic response to aripiprazole in healthy male volunteers.
    Kim E; Kwon JS; Shin YW; Lee JS; Kang WJ; Jo HJ; Lee JM; Yu KS; Kang DH; Cho JY; Jang IJ; Shin SG
    Pharmacogenet Genomics; 2008 Feb; 18(2):91-7. PubMed ID: 18192895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between smoking habits and dopamine receptor D2 taqI A A2 allele in Japanese males: a confirmatory study.
    Hamajima N; Ito H; Matsuo K; Saito T; Tajima K; Ando M; Yoshida K; Takahashi T
    J Epidemiol; 2002 Jul; 12(4):297-304. PubMed ID: 12395869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional polymorphism of -141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia.
    Ohara K; Nagai M; Tani K; Nakamura Y; Ino A; Ohara K
    Psychiatry Res; 1998 Nov; 81(2):117-23. PubMed ID: 9858029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An association study between the Cys311 variant of dopamine D2 receptor gene and schizophrenia in the Okinawan population.
    Kaneshima M; Higa T; Nakamoto H; Nagamine M
    Psychiatry Clin Neurosci; 1997 Dec; 51(6):379-81. PubMed ID: 9472122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms.
    Himei A; Koh J; Sakai J; Inada Y; Akabame K; Yoneda H
    Psychiatry Clin Neurosci; 2002 Feb; 56(1):97-102. PubMed ID: 11929577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients.
    Suzuki A; Mihara K; Kondo T; Tanaka O; Nagashima U; Otani K; Kaneko S
    Pharmacogenetics; 2000 Jun; 10(4):335-41. PubMed ID: 10862524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An association study of dopaminergic (DRD2) and serotoninergic (5-HT2) gene polymorphism and schizophrenia in a North Indian population.
    Kaur G; Singh Chavan B; Gupta D; Sinhmar V; Prasad R; Tripathi A; Garg PD; Gupta R; Khurana H; Gautam S; Margoob MA; Aneja J
    Asian J Psychiatr; 2019 Jan; 39():178-184. PubMed ID: 30389402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia.
    Ohara K; Nakamura Y; Xie DW; Ishigaki T; Deng ZL; Tani K; Zhang HY; Kondo N; Liu JC; Miyasato K; Ohara K
    Biol Psychiatry; 1996 Dec; 40(12):1209-17. PubMed ID: 8959285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between the tryptophan hydroxylase gene and the serotonin transporter gene in schizophrenia but not in bipolar or unipolar affective disorders.
    Chotai J; Serretti A; Lorenzi C
    Neuropsychobiology; 2005; 51(1):3-9. PubMed ID: 15627807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between Taq1 a dopamine D2 receptor polymorphism and psychopathology of schizophrenia in Japanese patients.
    Suzuki A; Kondo T; Mihara K; Furukori H; Nagashima U; Ono S; Otani K; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Oct; 24(7):1105-13. PubMed ID: 11131175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C957T DRD2 polymorphism is associated with schizophrenia in Spanish patients.
    Hoenicka J; Aragüés M; Rodríguez-Jiménez R; Ponce G; Martínez I; Rubio G; Jiménez-Arriero MA; Palomo T;
    Acta Psychiatr Scand; 2006 Dec; 114(6):435-8. PubMed ID: 17087792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The Cys allele of the DRD2 (Ser311Cys polymorphism) is associated with schizophrenia and worse sustained attention in patients].
    Golimbet VE; Lebedeva IS; Monakhov MV; Korovaĭtseva GI; Lezheĭko TV; Abramova LI; Kaleda VG; Karpov VL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(9):67-70. PubMed ID: 19770837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Pharmacogenetic Markers of CYP2D6 and DRD2 on Prolactin Response in Risperidone-Treated Thai Children and Adolescents With Autism Spectrum Disorders.
    Sukasem C; Hongkaew Y; Ngamsamut N; Puangpetch A; Vanwong N; Chamnanphon M; Chamkrachchangpada B; Sinrachatanant A; Limsila P
    J Clin Psychopharmacol; 2016 Apr; 36(2):141-6. PubMed ID: 26872113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of dopamine D2 receptor (DRD2) gene polymorphisms in cannabinoid addicts.
    Nacak M; Isir AB; Balci SO; Pehlivan S; Benlier N; Aynacioglu S
    J Forensic Sci; 2012 Nov; 57(6):1621-4. PubMed ID: 22536882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between the DRD2-141C Insertion/Deletion polymorphism and schizophrenia.
    Cordeiro Q; Siqueira-Roberto J; Zung S; Vallada H
    Arq Neuropsiquiatr; 2009 Jun; 67(2A):191-4. PubMed ID: 19547807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.